Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor.
In vivo studies of the metastatic process are severely hampered by the fact that most human tumor cell lines derived from highly metastatic tumors fail to consistently metastasize in immunodeficient mice like nude mice. We describe a model system based on a highly immunodeficient double knockout mou...
Guardado en:
Autores principales: | Patrizia Nanni, Giordano Nicoletti, Arianna Palladini, Stefania Croci, Annalisa Murgo, Marianna L Ianzano, Valentina Grosso, Valeria Stivani, Agnese Antognoli, Alessia Lamolinara, Lorena Landuzzi, Emmanuelle di Tomaso, Manuela Iezzi, Carla De Giovanni, Pier-Luigi Lollini |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/84ef216e802b4cee8d005229b86ae354 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Preclinical therapy of disseminated HER-2⁺ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus.
por: Patrizia Nanni, et al.
Publicado: (2013) -
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression
por: Veronica Giusti, et al.
Publicado: (2021) -
RAG2 and XLF/Cernunnos interplay reveals a novel role for the RAG complex in DNA repair
por: Chloé Lescale, et al.
Publicado: (2016) -
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft
por: Lorena Landuzzi, et al.
Publicado: (2021) -
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations
por: Patrizia Nanni, et al.
Publicado: (2019)